Delivery Order SPE2DB20D3101-SPE2DB25FRQE1
- Not listed
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Tivicay 50 mg tablets (30-count) valued at $2,871.67 on July 25, 2025, with completion expected by July 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,334.31 to AmerisourceBergen Drug Corp for the supply of Tivicay 50 mg tablets (30-count) on May 2, 2025, with an ultimate completion date of May 5, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order under its substantial Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Tivicay 50 mg tablets in quantities of 30, with a contract ceiling value of $23,342.52. This firm fixed-price delivery order, which is expected to be completed by August 26, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was...
- The Defense Logistics Agency awarded a $4,002.93 delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Tivicay 50 mg tablets (30-count packaging). This competitive award, with no set-aside designation, is a firm fixed-price contract that will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of June 17, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Tivicay 50 mg tablets (30-count packages) valued at $4,002.96 under a firm fixed-price contract. This non-set-aside award represents a single delivery order fulfilling pharmaceutical procurement needs for federal medical supply requirements. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a delivery order valued at $14,232.72 to AmerisourceBergen Drug Corp for the supply of Tivicay 50 mg tablets (30-count units). The contract is a firm fixed-price delivery order with no set-aside designation, competitively awarded on November 26, 2025, with an ultimate completion date of November 28, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a $2,797.68 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Tivicay 50 mg tablets (30-count units). This is a non-set-aside competitive award issued on December 19, 2025, with an ultimate completion date of December 22, 2025. The product will be performed and delivered from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $6,928.84 to AmerisourceBergen Drug Corp for Tivicay 50 mg tablets (30-count packages) on August 27, 2025, with completion scheduled for August 28, 2025. This competitively awarded, firm fixed-price delivery order represents a single-item pharmaceutical procurement with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this requirement...
- The Defense Logistics Agency awarded a delivery order valued at $24,055.34 to AmerisourceBergen Drug Corp for the supply of TIVICAY 50 mg tablets (30-count packages) on August 5, 2025, with completion scheduled for August 6, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 30 tablets of Tivicay 50 mg with a ceiling value of $11,725.91. Issued on June 6, 2025, this firm fixed-price delivery order is set to be completed by June 9, 2025. The contract will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. This award represents a competitive, non-set-aside procurement issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRQE1Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 15, 2025, for the supply of Tivicay 50 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $4,178.97. This delivery order represents a non-set-aside award issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle valued through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 16, 2025. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen Drug Corp supplies a comprehensive range of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains to support military and veteran healthcare systems. The Tivicay delivery exemplifies the company's role as a critical vendor within the DLA's pharmaceutical supply chain, fulfilling antiretroviral medication requirements for the Defense Health Agency and other government healthcare systems. AmerisourceBergen's demonstrated capability to compete successfully for federal contracts across varying order values, combined with its established position as a prime vendor under the DLA's global pharmaceutical program, underscores its significance in supporting military medical readiness and healthcare delivery worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 7/15/25 |